NOVORAPID PENFIL

About

NOVORAPID PENFIL 1 contains Insulin Aspart, a rapid-acting insulin analogue, indicated for the treatment of diabetes mellitus. Insulin Aspart is genetically engineered to have a faster onset and shorter duration of action compared to regular human insulin. This rapid action allows it to be administered immediately before a meal (0-10 minutes) or even shortly after, effectively covering the postprandial glucose rise. Its quick absorption and peak effect, typically within 1-2 hours, help to minimize the risk of post-meal hyperglycemia. NOVORAPID is suitable for both type 1 and type 2 diabetes patients who require mealtime insulin to achieve optimal glycemic control. The Penfill cartridges are designed for use with compatible insulin pens, providing a convenient and precise method of insulin delivery, crucial for flexible meal planning and lifestyle management.

Uses

• Treatment of type 1 diabetes mellitus.
• Treatment of type 2 diabetes mellitus.
• Mealtime insulin for postprandial glucose control.
• Correction doses for high blood sugar.

Directions For Use

Inject subcutaneously immediately before a meal (0-10 minutes) or shortly after. Rotate injection sites within the same region.

Benefits

• Very rapid onset of action.
• Effective for post-meal glucose control.
• Offers flexibility in meal timing.
• Reduced risk of post-meal hyperglycemia.
• Can be used in insulin pumps.
• Convenient pre-filled pen cartridges.

Side Effects

• Hypoglycemia (low blood sugar).
• Injection site reactions (pain, redness, itching, swelling).
• Lipodystrophy (fat accumulation or atrophy at injection site).
• Weight gain.
• Peripheral edema (swelling of extremities).
• Allergic reactions (rash, hives, shortness of breath).
• Pruritus (itching).
• Blurred vision (temporary, due to blood sugar changes).
• Headache.
• Flu-like symptoms.
• Antibody formation.
• Diabetic retinopathy worsening (rare).

Safety Measures

• Alcohol - Alcohol can potentiate the hypoglycemic effect of insulin; use with caution and monitor blood glucose closely.
• Pregnancy - Generally considered safe, but close monitoring and dose adjustment are crucial. Consult your doctor for personalized advice.
• Breastfeeding - Insulin is generally safe during breastfeeding, but monitor mother and infant for any adverse effects.
• Liver - Dose adjustment may be required in hepatic impairment due to altered glucose metabolism; consult your physician.
• Kidney - Dose adjustment may be required in renal impairment due to altered glucose metabolism; consult your physician.
• Lung - No specific contraindication, but general caution should be exercised in patients with severe underlying medical conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.